Skip to main content
. Author manuscript; available in PMC: 2011 May 4.
Published in final edited form as: Toxicol Lett. 2010 Feb 13;194(3):79–85. doi: 10.1016/j.toxlet.2010.02.009

Fig. 3. Both CD4+ and CD8+ subsets of TFA-specific T cells were generated in BALB/cByJ mice immunized by TFA-MSA and the combined CD40/CpG agonist.

Fig. 3

Female BALB/cByJ mice were injected i.p. with 0.5 mg of TFA-MSA, 40 µg of anti-CD40 Ab, and 100 µg of CpG. One week later, mice were sacrificed and splenocytes isolated. CD4+ or CD8+ T cells were further purified by using a T cell enrichment kit. Subsequently, 2.5× 106 of CD4+ T cells (A) and 1.25× 106 of CD8+ T cells(B) per well of 48-well plate were cultured with naïve splenocytes (1 × 106 cells/well), which served as APCs, in the presence of various antigens (50 µg /ml) for 48 h. IFN-γ production was measured in the supernatant by ELISA. The measurements were carried out in triplicate and the results shown represent mean ± SEM of 3 mice per group. *P<0.05 compared with the LMNC stimulated with CCH. The data shown is the representative of two independent experiments.